SCHEMBL20465205

SCHEMBL20465205

CC1(C)c2ccccc2-c2c(-c3nc(-c4cccc(-c5cccnc5)c4)nc(-c4cccc(-c5cccnc5)c4)n3)cccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 6/20 0.46
CYP11B1 P15538 3/20 0.40
CYP17A1 P05093 2/20 0.40
CYP19A1 P11511 2/20 0.40
CYP11B2 P19099 2/20 0.40
BACE1 P56817 2/20 0.40
KCNH2 Q12809 1/20 0.40
MEN1 O00255 1/20 0.38
PSIP1 O75475 1/20 0.38
AXL P30530 1/20 0.38
MKNK1 Q9BUB5 1/20 0.38
MKNK2 Q9HBH9 1/20 0.38
KMO O15229 1/20 0.38
ALDH1A1 P00352 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2A6 P11509 1/20 0.37
EPHX2 P34913 1/20 0.36
PRMT6 Q96LA8 1/20 0.36
KDM4E B2RXH2 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22038354 0.95 PDK2 (0.43) PDK2CYP11B1CYP17A1CYP19A1CYP11B2
SCHEMBL18463302 0.91 PDK2 (0.47) PDK2CYP11B1CYP17A1CYP19A1CYP11B2
SCHEMBL22037525 0.91 PDK2 (0.46) PDK2CYP11B1CYP17A1CYP19A1CYP11B2
SCHEMBL22037622 0.91 PDK2 (0.46) PDK2CYP11B1CYP17A1CYP19A1CYP11B2
SCHEMBL22037962 0.91 PDK2 (0.47) PDK2CYP11B1CYP17A1CYP19A1CYP11B2
SCHEMBL22037903 0.90 PDK2 (0.46) PDK2CYP11B1CYP17A1CYP19A1CYP11B2
SCHEMBL18463301 0.90 PDK2 (0.46) PDK2CYP11B1CYP17A1CYP19A1CYP11B2
SCHEMBL22039069 0.90 PDK2 (0.46) PDK2CYP11B1CYP17A1CYP19A1CYP11B2
SCHEMBL22038363 0.90 PDK2 (0.46) PDK2CYP11B1CYP17A1CYP19A1CYP11B2
SCHEMBL22038494 0.89 PDK2 (0.46) PDK2CYP11B1CYP17A1CYP19A1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180222872-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2018-08-09 US disclosed
US-20180222872-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2018-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180222872-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES PIEZO1, NES, PIR PDK2 364/4885CYP11B1 4080/4885CYP17A1 4501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.